Protara Therapeutics's total assets for Q3 2025 were $144.64M, a decrease of -7.84% from the previous quarter. TARA total liabilities were $12.35M for the fiscal quarter, a -1.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.